Greenwich LifeSciences Statistics
Total Valuation
GLSI has a market cap or net worth of $155.44 million. The enterprise value is $148.45 million.
| Market Cap | 155.44M |
| Enterprise Value | 148.45M |
Important Dates
The last earnings date was Monday, April 15, 2024, after market close.
| Earnings Date | Apr 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GLSI has 12.88 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Shares Outstanding | 12.88M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 52.58% |
| Owned by Institutions (%) | 4.86% |
| Float | 5.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 23.20 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.76, with zero debt.
| Current Ratio | 23.76 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.90% and return on invested capital (ROIC) is -139.21%.
| Return on Equity (ROE) | -93.90% |
| Return on Assets (ROA) | -91.20% |
| Return on Capital (ROIC) | -139.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.96M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.25% in the last 52 weeks. The beta is 3.19, so GLSI's price volatility has been higher than the market average.
| Beta (1Y) | 3.19 |
| 52-Week Price Change | +8.25% |
| 50-Day Moving Average | 14.98 |
| 200-Day Moving Average | 10.97 |
| Relative Strength Index (RSI) | 30.05 |
| Average Volume (30 Days) | 50,853 |
Short Selling Information
The latest short interest is 140,464, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 140,464 |
| Short Previous Month | 137,047 |
| Short % of Shares Out | 1.09% |
| Short % of Float | 2.40% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.33M |
| Pretax Income | -8.89M |
| Net Income | -8.89M |
| EBITDA | -8.89M |
| EBIT | -8.89M |
| Earnings Per Share (EPS) | -$0.69 |
Balance Sheet
The company has $6.99 million in cash and no debt, giving a net cash position of $6.99 million or $0.54 per share.
| Cash & Cash Equivalents | 6.99M |
| Total Debt | n/a |
| Net Cash | 6.99M |
| Net Cash Per Share | $0.54 |
| Equity / Book Value | 6.70M |
| Book Value Per Share | 0.52 |
| Working Capital | 6.70M |
Cash Flow
| Operating Cash Flow | -6.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.48M |
| FCF Per Share | -$0.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLSI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 0.51% |
| Earnings Yield | -5.72% |
| FCF Yield | -4.17% |
Analyst Forecast
The average price target for GLSI is $36.00, which is 198.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.00 |
| Price Target Difference | 198.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |